“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition that has been reported in children who have been infected with COVID-19 or have been exposed to someone with COVID-19. MIS-C is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. It can occur weeks after a child has had COVID-19, even if they had no symptoms or only mild symptoms of the virus.
The exact cause of MIS-C is not known, but it is thought to be related to an immune response triggered by the COVID-19 virus. Children with MIS-C may have a fever, abdominal pain, vomiting, diarrhea, rash, red eyes, or a feeling of being unwell. They may also have other symptoms, such as chest pain, shortness of breath, or a fast heartbeat, which may indicate inflammation of the heart or lungs.
MIS-C is a serious condition that requires prompt medical attention. Treatment may involve hospitalization and supportive care, including intravenous fluids, oxygen therapy, and medications to reduce inflammation. In some cases, more intensive treatments may be necessary, such as mechanical ventilation or extracorporeal membrane oxygenation (ECMO), which is a procedure that provides life support for the heart and lungs.
Prevention of MIS-C involves preventing COVID-19 infection in children. This includes following public health guidelines such as wearing masks, social distancing, frequent hand washing, and avoiding large gatherings. Vaccines are also available for children and adults to prevent COVID-19 and reduce the risk of developing MIS-C. If a child has symptoms of MIS-C or has been in contact with someone with COVID-19, they should be evaluated by a healthcare provider.
The exact cause of MIS-C is not known yet, but it appears to be an excessive immune response related to COVID-19. Many children with MIS-C have a positive antibody test result. This means they've had a recent infection with the COVID-19 virus. Some may have a current infection with the virus.
In the U.S., the Pfizer-BioNTech COVID-19 vaccine is now available to people age 5 and older. A vaccine can prevent you or your child from getting or spreading the COVID-19 virus. If you or your child gets COVID-19, a COVID-19 vaccine could or prevent you or your child from becoming seriously ill. Also, if you and your child have been fully vaccinated, you and your child can more safely return to many activities you may not have been able to do because of the pandemic.
If you or your child haven’t been vaccinated, you can take many steps to prevent yourselves from getting the COVID-19 virus and spreading it to others. The CDC recommends following these precautions for avoiding exposure to the virus that causes COVID-19:
Most children with MIS-C need to be treated in a hospital. Some need treatment in a pediatric intensive care unit. Treatment usually involves supportive care and measures to reduce inflammation in any affected vital organs to protect them from permanent damage. Treatment depends on the type and severity of symptoms and which organs and other parts of the body are affected by inflammation.
Supportive care may include:
Treatment to reduce swelling and inflammation may include:
There is no evidence that MIS-C is contagious. But there's a chance that your child could have an active infection with the COVID-19 virus or another type of contagious infection. So the hospital will use infection control measures while caring for your child.